Literature DB >> 32893887

Blood and cerebrospinal fluid immune cell profiles in patients with temporal lobe epilepsy of different etiologies.

Lisa Langenbruch1, Laurens Bleß1, Andreas Schulte-Mecklenbeck1, Benedikt Sundermann2,3, Tobias Brix4, Christian E Elger1, Nico Melzer1, Heinz Wiendl1, Sven G Meuth1, Catharina C Gross1, Stjepana Kovac1.   

Abstract

Inflammation plays a role in the pathogenesis of immune-mediated epilepsy, but also in epilepsy of other etiology such as hippocampal sclerosis. This study aimed to characterize immune cell signatures in the peripheral blood (PB) and cerebrospinal fluid (CSF) in temporal lobe epilepsy (TLE) of different etiologies. We retrospectively evaluated CSF routine parameters and immune cell profiles using flow cytometry in a cohort of 51 patients and 45 age-matched controls with functional disorders. Groups were comprised of patients with nonlesional TLE (n = 26), TLE due to hippocampal sclerosis (n = 14), or limbic encephalitis with antibodies against the 65-kDa isoform of glutamic acid decarboxylase (GAD65-LE; n = 11). TLE patients showed increased proportions of human leukocyte antigen-DR isotype (HLA-DR)-expressing CD4+ T lymphocytes in the CSF. Furthermore, they were characterized by a shift in monocyte subsets toward immature CD14low CD16+ cells in the PB and blood/CSF-barrier dysfunction. Whereas TLE patients in general showed similar immune cell profiles, patients with GAD65-LE differed from other TLE patients by increased proportions of HLA-DR-expressing CD8+ T lymphocytes and type 2/3 oligoclonal bands. These findings point to a role of innate and adaptive immunity in TLE. CSF parameters may help to discriminate epilepsy patients from controls and different forms of TLE from each other.
© 2020 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Entities:  

Keywords:  autoimmune encephalitis; cerebrospinal fluid; flow cytometry; hippocampal sclerosis; immune signature; limbic encephalitis

Mesh:

Substances:

Year:  2020        PMID: 32893887     DOI: 10.1111/epi.16688

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  Hippocampal Cytokine Release in Experimental Epileptogenesis-A Longitudinal In Vivo Microdialysis Study.

Authors:  Kai Siebenbrodt; Vanessa Schütz; Lara S Costard; Valentin Neubert; Daniel Alvarez-Fischer; Kerstin Seidel; Bernd Schmeck; Sven G Meuth; Felix Rosenow; Sebastian Bauer
Journal:  Brain Sci       Date:  2022-05-21

2.  Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort.

Authors:  Niels Hansen; Berend Malchow; Inga Zerr; Winfried Stöcker; Jens Wiltfang; Charles Timäus
Journal:  J Neural Transm (Vienna)       Date:  2021-03-06       Impact factor: 3.575

Review 3.  Advances regarding Neuroinflammation Biomarkers with Noninvasive Techniques in Epilepsy.

Authors:  Hongrui Ma; Hua Lin
Journal:  Behav Neurol       Date:  2021-12-22       Impact factor: 3.342

Review 4.  Catatonic Schizophrenia Associated With Cerebrospinal GAD65 Autoantibodies: Case Report and Literature Review.

Authors:  Niels Hansen; Claudia Bartels; Bianca Teegen; Jens Wiltfang; Berend Malchow
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

Review 5.  Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities.

Authors:  Ferdinand Otto; Christine Harrer; Georg Pilz; Peter Wipfler; Andrea Harrer
Journal:  Diagnostics (Basel)       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.